Sino Biopharmaceutical : VOLUNTARY ANNOUNCEMENT - "TIAN NENG" OBTAINS REGISTRATION CERTIFICATE OF FORMULA FOOD FOR SPECIAL MEDICAL PURPOSE

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

(Incorporated in the Cayman Islands with limited liability)

Website: www.sinobiopharm.com

(Stock code: 1177)

VOLUNTARY ANNOUNCEMENT

"TIAN NENG" OBTAINS REGISTRATION CERTIFICATE OF FORMULA FOOD

FOR SPECIAL MEDICAL PURPOSE

The board of directors (the "Board") of Sino Biopharmaceutical Limited (the "Company", together with its subsidiaries, the "Group") announces that "Tian Neng" (an electrolyte formula food for special medical purpose), a component nutritional product of the Group, is granted the approval for registration by the State Administration for Market Regulation and obtains the registration certification of formula food for special medical purpose. This product is suitable for replenishment of water and electrolytes for children with diarrhea and fever.

Tian Neng, an upgrade product of the third-generation oral rehydration salt, is the only preparation containing the oligo-element zinc among domestic oral rehydration salt related products. The product can replenish water and stop diarrhea of patients through regulating the balance of intestinal water and electrolyte metabolism. Tian Neng features major advantages of (1) a fruity taste that is different from the bitter taste of other oral rehydration salts, resulting in good compliance by children; (2) an enhanced zinc-containing formula to boost the immunity of patients; and (3) applicability to patients with diarrhea and fever.

In addition to Tian Neng, the Group has also launched a number of component nutritional products, including "Su Qian", the oral pre-operative carbohydrate component formula food for special medical purpose. The Group also has the capability and core technologies for the production and development of complete nutritional, specific nutritional, and functional foods, thus strengthening its presence in all aspects in the special medical sector.

1

By order of the Board

Sino Biopharmaceutical Limited

Chairwoman

Tse, Theresa Y Y

Hong Kong, 29 April 2021

As at the date of this announcement, the Board of the Company comprises nine Executive Directors, namely Ms. Tse, Theresa Y Y, Mr. Tse Ping, Ms. Cheng Cheung Ling, Mr. Tse, Eric S Y, Mr. Tse Hsin, Mr. Li Yi, Mr. Wang Shanchun, Mr. Tian Zhoushan and Ms. Li Mingqin and five Independent Non- Executive Directors, namely Mr. Lu Zhengfei, Mr. Li Dakui, Ms. Lu Hong, Mr. Zhang Lu Fu and Mr. Li Kwok Tung Donald.

2